1. 6ER-016 Clinical trials: therapeutic opportunities, economic impact and savings for the national health system. (March 2019) Authors: Borchetto, SL; Taddei, B; Beretta, F; Ferrante, D; Marchesi, F; Nozza, S; Daminelli, M; Gregis, F; Gatti, V; Sottocorno, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6ER-016 Economic value of unused high cost experimental infusion drugs: a potential saving for the national health system. (24th March 2020) Authors: Borchetto, SL; Taddei, B; Marchesi, F; Nozza, S; Gregis, F; Gatti, V; Rossi, L Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study). (15th June 2020) Authors: Nozza, S; Ferrarese, R; Poli, A; Galli, L; Sampaolo, M; Bigoloni, A; Galli, A; Muccini, C; Spagnuolo, V; Lazzarin, A; Clementi, M; Mancini, N; Castagna, A Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 9(2020) Page Start: 2700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy. (June 2019) Authors: Damuzzo, V; Russi, A; Chiumente, M; Masini, C; Rebesco, B; Gregis, F; Nozza, S; Pigozzo, J; Chiarion-Sileni, V; Palozzo, AC Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 4(2019) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. Issue 8 (24th June 2020) Authors: Taramasso, L; Fabbiani, M; Nozza, S; De Benedetto, I; Bruzzesi, E; Mastrangelo, A; Pinnetti, C; Calcagno, A; Ferrara, M; Bozzi, G; Focà, E; Quiros‐Roldan, E; Ripamonti, D; Campus, M; Celesia, BM; Torti, C; Cosco, L; Di Biagio, A; Rusconi, S; Marchetti, G Journal: HIV medicine Issue: Volume 21:Issue 8(2020) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2). (4th March 2020) Authors: Maggiolo, F; Gianotti, N; Comi, L; Di Filippo, E; Fumagalli, L; Nozza, S; Galli, L; Valenti, D; Rizzi, M; Castagna, A Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 5(2020) Page Start: 1332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗